Figure 3
From: PKM2 is a potential prognostic biomarker and related to immune infiltration in lung cancer
Analysis of the mRNA and protein expression levels of PKM2 in tumor and adjacent normal tissues of lung cancer. RNA-seq (A) and gene chip (B) data from the KM plotter database were used to compare the expression levels of PKM2 in tumor and adjacent normal tissues. (C) Correlation between PKM2 expression and tumor stage in LUAD and LUSC (GEPIA database). (D) PKM2 protein expression levels in tumors and adjacent normal tissues of LUAD and LUSC patients were detected by immunohistochemistry in the HPA database.
